Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20280312 | 1.00 | GAA (0.31) | GAAPOLBTDP1TSHR | |
| SCHEMBL3309020 | 0.97 | TSHR (0.33) | POLBTDP1TSHR | |
| SCHEMBL10796699 | 0.93 | GAA (0.31) | GAAPOLBTDP1 | |
| SCHEMBL8909769 | 0.93 | GAA (0.31) | GAAPOLBTDP1 | |
| SCHEMBL16161480 | 0.93 | GAA (0.31) | GAAPOLBTDP1 | |
| SCHEMBL19293544 | 0.93 | GAA (0.31) | GAAPOLBTDP1 | |
| SCHEMBL13276440 | 0.90 | KDM4E (0.33) | GAAPOLBTDP1 | |
| SCHEMBL60409 | 0.90 | KDM4E (0.33) | GAAPOLBTDP1 | |
| SCHEMBL6469498 | 0.90 | KDM4E (0.33) | GAAPOLBTDP1 | |
| SCHEMBL6245109 | 0.90 | KDM4E (0.33) | GAAPOLBTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3786216-B1 | PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING | CYTEC TECH CORP (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4605460-A1 | SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION | Cytec Industries Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| EP-3137540-B1 | STABILIZING COMPOSITIONS FOR STABILIZING MATERIALS AGAINST ULTRAVIOLET LIGHT AND THERMAL DEGRADATION | CYTEC IND INC (US) | 2024-10-30 | — | — | EP | claimed |
| WO-2024083872-A1 | SYNERGISTIC STABILIZER COMPOSITIONS AND METHODS FOR USING SAME FOR PROTECTING ORGANIC MATERIALS FROM UV LIGHT AND THERMAL DEGRADATION | CYTEC INDUSTRIES INC. (US) | 2024-04-25 | — | — | WO | claimed |
| EP-2864310-B1 | STABILIZER COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND METHODS OF USE | CYTEC TECH CORP (US) | 2022-10-26 | — | — | EP | claimed |
| EP-0042622-B1 | Spiro[2,2,6,6-tetramethyl-piperidine-4,2'-(1',3'-dioxo(ol)an]-derivatives and stabilizers for synthetic polymers | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1987-08-19 | — | — | EP | claimed |
| EP-4705570-A1 | WOOD DIGESTION PROCESS | Technikum Laubholz GmbH (DE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4676920-A1 | PHOTOLABILE CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED DELIVERY OF ACTIVE ALDEHYDES AND KETONES | Firmenich SA (CH) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024227791-A1 | WOOD DIGESTION PROCESS | TECHNIKUM LAUBHOLZ GMBH (DE) | 2024-11-07 | — | — | WO | disclosed |
| US-12134602-B2 | (−)-huperzine A processes and related compositions and methods of treatment | YALE UNIVERSITY (US) | 2024-11-05 | — | — | US | disclosed |
| WO-2024218086-A1 | PHOTOLABILE CYCLIC ACETALS AND KETALS FOR THE LIGHT-INDUCED DELIVERY OF ACTIVE ALDEHYDES AND KETONES | FIRMENICH SA (CH) | 2024-10-24 | — | — | WO | disclosed |
| US-20240219830-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240210824-A1 | CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2024-06-27 | — | — | US | disclosed |
| US-5614550-A | ANTICHOLESTEROL AGENTS OR ARTERIOSCLEROSIS AGENTS FOR HUMANS | SANKYO COMPANY, LIMITED (JP) | 1997-03-25 | — | — | US | disclosed |
| US-5534529-A | Substituted aromatic amides and ureas derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY, LIMITED (JP) | 1996-07-09 | — | — | US | disclosed |
| EP-0632036-A2 | Amide and urea derivatives having anti-hypercholesteremic activity, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1995-01-04 | — | — | EP | disclosed |
| US-4851461-A | PHOTOSTABILIZERS | ICI AMERICAS INC. (US) | 1989-07-25 | — | — | US | disclosed |
| EP-0291239-A2 | Glutarate based stabilisers for plastics | ICI AMERICAS INC. (US) | 1988-11-17 | — | — | EP | disclosed |
| EP-0042622-B1 | Spiro[2,2,6,6-tetramethyl-piperidine-4,2'-(1',3'-dioxo(ol)an]-derivatives and stabilizers for synthetic polymers | ADEKA ARGUS CHEMICAL CO., Ltd. (JP) | 1987-08-19 | — | — | EP | disclosed |
| US-3960945-A | 4-[-(Alkoxy or polyhaloalkoxy)-benzamido]cyclohexanones | STERLING DRUG INC. (US) | 1976-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240210824-A1 | CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | SCO2, CBR1, OXGR1 | GAA 3762/4885POLB 877/4885TDP1 4539/4885 |
| US-12134602-B2 | (−)-huperzine A processes and related compositions and methods of treatment | CHRNA5, HTR2A, GRIK5 | GAA 370/4885POLB 2592/4885TDP1 501/4885 |
| US-20240219830-A1 | SALT, ACID GENERATOR, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN | H1-0, HCN3, RER1 | GAA 4586/4885POLB 687/4885TDP1 4514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.